- Study: Higher levels of sleep aid melatonin may reduce prostate cancer risk
- FDA advisory committee recommends approval of Vanda Pharmaceuticals' Hetlioz for non-24-hour disorder in the totally blind
- Sweet Dreams collection makes its debut
- Walgreens partners with family support group Tomorrow's Child
- 5-Hour Energy heads to Twitter to perk up
SCOTTSDALE, Ariz. — Crown Dynamics on Wednesday launched its patented Air Sleep/Snore product line. The products are infused with a proprietary blend of therapeutic essential oils shown to promote sleep while gently dilating nasal passages to help increase oxygen flow and decrease snoring.
"After years of research and development, we're excited that we can deliver to consumers a product that is unlike anything else found in the market today," stated David Dolezal, president of Airware Labs. "We're proud to offer our unique AIR Sleep/Snore product, which combines essential oils with our AIR Breathe product that has been clinically proven to significantly reduce snoring."
The active ingredient is lavender — University of Maryland researchers have confirmed that lavender produces slight calming, soothing and sedative effects when it is scent is inhaled.
Crown Dynamics' Airware Labs recently published a clinical trial designed to determine the efficacy of its AIR Breathe products for users and sleep quality for their partners. The product, which acts as an internal nasal dilator as opposed to adhesive nasal strips placed on the outside of the nose, demonstrated substantial alleviation of snoring in AIR Breathe users, resulting in sounder, more restful sleep for users, as well as 88% of their bed partners.
The clinical research findings were published in the September-October issue of Sleep Diagnosis and Therapy.